ATE122559T1 - Proliposomales pulver für polyenliposomen sowie verfahren zu dessen herstellung. - Google Patents

Proliposomales pulver für polyenliposomen sowie verfahren zu dessen herstellung.

Info

Publication number
ATE122559T1
ATE122559T1 AT92905027T AT92905027T ATE122559T1 AT E122559 T1 ATE122559 T1 AT E122559T1 AT 92905027 T AT92905027 T AT 92905027T AT 92905027 T AT92905027 T AT 92905027T AT E122559 T1 ATE122559 T1 AT E122559T1
Authority
AT
Austria
Prior art keywords
polyene
solution
combining
liposomes
production
Prior art date
Application number
AT92905027T
Other languages
English (en)
Inventor
Robert P Lenk
Reeta Mehta
Gabriel Lopez-Berestein
Original Assignee
Univ Texas
Argus Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas, Argus Pharm Inc filed Critical Univ Texas
Application granted granted Critical
Publication of ATE122559T1 publication Critical patent/ATE122559T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]
    • Y10T428/2985—Solid-walled microcapsule from synthetic polymer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Saccharide Compounds (AREA)
AT92905027T 1991-01-14 1992-01-10 Proliposomales pulver für polyenliposomen sowie verfahren zu dessen herstellung. ATE122559T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/640,707 US5178875A (en) 1991-01-14 1991-01-14 Liposomal-polyene preliposomal powder and method for its preparation

Publications (1)

Publication Number Publication Date
ATE122559T1 true ATE122559T1 (de) 1995-06-15

Family

ID=24569381

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92905027T ATE122559T1 (de) 1991-01-14 1992-01-10 Proliposomales pulver für polyenliposomen sowie verfahren zu dessen herstellung.

Country Status (11)

Country Link
US (2) US5178875A (de)
EP (1) EP0567582B1 (de)
JP (1) JP3267611B2 (de)
AT (1) ATE122559T1 (de)
AU (1) AU663074B2 (de)
CA (1) CA2099771C (de)
DE (1) DE69202559T2 (de)
DK (1) DK0567582T3 (de)
ES (1) ES2074878T3 (de)
GR (1) GR3017118T3 (de)
WO (1) WO1992011842A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830498A (en) * 1987-10-16 1998-11-03 Board Of Regents, The University Of Texas System Liposomal-polyene preliposomal powder and method for its preparation
US5178875A (en) * 1991-01-14 1993-01-12 The Board Of Regents, The University Of Texas System Liposomal-polyene preliposomal powder and method for its preparation
US5417978A (en) * 1993-07-29 1995-05-23 Board Of Regents, The University Of Texas System Liposomal antisense methyl phosphonate oligonucleotides and methods for their preparation and use
US5902604A (en) * 1995-06-06 1999-05-11 Board Of Regents, The University Of Texas System Submicron liposome suspensions obtained from preliposome lyophilizates
US5855911A (en) * 1995-08-29 1999-01-05 Board Of Regents, The University Of Texas System Liposomal phosphodiester, phosphorothioate, and P-ethoxy oligonucleotides
US6977244B2 (en) 1996-10-04 2005-12-20 Board Of Regents, The University Of Texas Systems Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
GB2326337A (en) * 1997-06-20 1998-12-23 Phares Pharma Holland Homogeneous lipid compositions for drug delivery
US6287590B1 (en) * 1997-10-02 2001-09-11 Esperion Therapeutics, Inc. Peptide/lipid complex formation by co-lyophilization
US7285288B1 (en) 1997-10-03 2007-10-23 Board Of Regents, The University Of Texas System Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
US7704962B1 (en) 1997-10-03 2010-04-27 Board Of Regents, The University Of Texas System Small oligonucleotides with anti-tumor activity
US20010003580A1 (en) 1998-01-14 2001-06-14 Poh K. Hui Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
CA2318556A1 (en) * 1998-01-16 1999-07-22 Biomira, Inc. Lipomatrix preparation
EP1059941B1 (de) * 1998-03-05 2004-05-26 Phares Pharmaceutical Research N.V. Arzneimittel und deren verwendung
US6106701A (en) * 1998-08-25 2000-08-22 Betzdearborn Inc. Deasphalting process
US6613352B2 (en) 1999-04-13 2003-09-02 Universite De Montreal Low-rigidity liposomal formulation
US6413537B1 (en) 2000-03-10 2002-07-02 Wisconsin Alumni Research Foundation Nystatin formulation having reduced toxicity
US20040082521A1 (en) * 2002-03-29 2004-04-29 Azaya Therapeutics Inc. Novel formulations of digitalis glycosides for treating cell-proliferative and other diseases
JP2006508126A (ja) * 2002-11-06 2006-03-09 アザヤ セラピューティクス インコーポレイティッド 薬学的製剤のタンパク質安定化されたリポソーム製剤
US8895717B2 (en) 2005-04-15 2014-11-25 The Board Of Regents Of The University Of Texas System Delivery of siRNA by neutral lipid compositions
JP2009519250A (ja) * 2005-12-08 2009-05-14 ワイス リポソーム組成物
EP2368627A4 (de) 2008-12-24 2015-01-14 Biomedcore Inc Verfahren zur herstellung von liposomen und verfahren zur cholesterinauflösung
JP5771366B2 (ja) 2009-09-02 2015-08-26 株式会社バイオメッドコア リポソーム製造装置及び方法
WO2013142184A1 (en) 2012-03-19 2013-09-26 Yale University Antimicrobial compositions and methods
JP2016079351A (ja) * 2014-10-22 2016-05-16 株式会社デンソー 複合蓄熱材
WO2016080336A1 (ja) * 2014-11-18 2016-05-26 国立研究開発法人物質・材料研究機構 多孔性粒子の製造方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1575343A (en) * 1977-05-10 1980-09-17 Ici Ltd Method for preparing liposome compositions containing biologically active compounds
CH621479A5 (de) * 1977-08-05 1981-02-13 Battelle Memorial Institute
FR2416008A1 (fr) * 1978-02-02 1979-08-31 Oreal Lyophilisats de liposomes
US4744989A (en) * 1984-02-08 1988-05-17 E. R. Squibb & Sons, Inc. Method of preparing liposomes and products produced thereby
EP0152379A3 (de) * 1984-02-15 1986-10-29 Ciba-Geigy Ag Verfahren zur Herstellung von pharmazeutischen Zusammensetzungen enthaltend unilamellare Liposomen
JPH0753661B2 (ja) * 1984-03-08 1995-06-07 フアレス フアーマスーチカル リサーチ エヌブイ プロ―リポソーム組成物及びリポソームの水性分散物を作る方法
JPS60208910A (ja) * 1984-03-31 1985-10-21 Green Cross Corp:The 水難溶性薬物・リン脂質複合体の製造方法
US4880635B1 (en) * 1984-08-08 1996-07-02 Liposome Company Dehydrated liposomes
JPS6150912A (ja) * 1984-08-16 1986-03-13 Shionogi & Co Ltd リポソ−ム製剤の製造法
JPS6176414A (ja) * 1984-09-21 1986-04-18 Shionogi & Co Ltd リポソーム製剤の製法
CA1260393A (en) * 1984-10-16 1989-09-26 Lajos Tarcsay Liposomes of synthetic lipids
US4897355A (en) * 1985-01-07 1990-01-30 Syntex (U.S.A.) Inc. N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US4830858A (en) * 1985-02-11 1989-05-16 E. R. Squibb & Sons, Inc. Spray-drying method for preparing liposomes and products produced thereby
CA1256372A (en) * 1985-04-11 1989-06-27 Koichiro Miyazima Process for producing liposome composition
US4766046A (en) * 1985-09-27 1988-08-23 Liposome Technology, Inc. Stabilized liposome/amphotericin composition and method
US4812312A (en) * 1987-03-03 1989-03-14 Board Of Regents Of The University Of Texas System Liposome-incorporated nystatin
NZ223660A (en) * 1987-03-05 1990-11-27 Liposome Co Inc Low toxicity drug-lipid complexes; methods of making them; and method of determining their toxicity
US4963362A (en) * 1987-08-07 1990-10-16 Regents Of The University Of Minnesota Freeze-dried liposome mixture containing cyclosporin
US4950432A (en) * 1987-10-16 1990-08-21 Board Of Regents, The University Of Texas System Polyene microlide pre-liposomal powders
US5178875A (en) * 1991-01-14 1993-01-12 The Board Of Regents, The University Of Texas System Liposomal-polyene preliposomal powder and method for its preparation
US4994213A (en) * 1988-05-17 1991-02-19 Liposome Technology, Inc. Method of preparing lipid structures
CA1340241C (en) * 1988-06-08 1998-12-15 Fountain Pharmaceuticals, Inc. Method for marking solvent dilution microcarriers
US4999199A (en) * 1988-11-10 1991-03-12 Board Of Regents, The University Of Texas System Pharmaceutical formulations: liposomes incorporating aromatic polyene antibiotics
US4935171A (en) * 1989-01-27 1990-06-19 Vestar, Inc. Method for vesicle formation
JP2798302B2 (ja) * 1989-03-31 1998-09-17 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア リポソームおよび脂質複合体組成物の調製

Also Published As

Publication number Publication date
JP3267611B2 (ja) 2002-03-18
US5965158A (en) 1999-10-12
AU663074B2 (en) 1995-09-28
GR3017118T3 (en) 1995-11-30
EP0567582A1 (de) 1993-11-03
ES2074878T3 (es) 1995-09-16
DE69202559D1 (de) 1995-06-22
US5178875A (en) 1993-01-12
DK0567582T3 (da) 1995-10-02
AU1252792A (en) 1992-08-17
DE69202559T2 (de) 1996-01-11
EP0567582B1 (de) 1995-05-17
JPH06509547A (ja) 1994-10-27
CA2099771C (en) 2002-04-23
CA2099771A1 (en) 1992-07-15
WO1992011842A1 (en) 1992-07-23

Similar Documents

Publication Publication Date Title
DE69202559D1 (de) Proliposomales pulver für polyenliposomen sowie verfahren zu dessen herstellung.
ATE53038T1 (de) Inositoltriphosphat, verfahren zu seiner herstellung und dieses enthaltende zubereitung.
ES8600931A1 (es) Un procedimiento para preparar una solucion acuosa que contiene una sustancia farmaceutica soluble en lipidos
ATE158175T1 (de) Liposomen, verfahren zu ihrer herstellung und ihre verwendung zur herstellung eines arzneimittels
DK0580817T3 (da) Farmaceutisk præparat og fremgangsmåde til fremstilling deraf
ES2188750T3 (es) Procedimiento para la preparacion de particulas respirables.
ATE231389T1 (de) Luv mit gesättigten phospholipiden und verfahren zu deren herstellung
DK629388A (da) Fremgangsmaade til fremstilling af amphotericin b liposome
KR850001691A (ko) 디하이드로피리딘 a 화합물의 속효성 고형제제의 제조방법
ATE219664T1 (de) Verfahren zur herstellung fester pharmazeutischer dosisformen
DE69920945D1 (de) Verfahren zur herstellung von arzneistoffpartikeln
HUT59818A (en) Process for producing lipide complex containing different components
DE59009603D1 (de) Verfahren zur Herstellung von Ascorbinsäure-2-phosphat bzw. dessen Salzen sowie Kaliummagnesium-L-ascorbat-2-phosphat als vorteilhaftes Salz von L-Ascorbinsäure-2-phosphat.
DE3382299D1 (de) Pyrazolo(3,4-b)pyridinderivate und verfahren zu ihrer herstellung.
DE69927602D1 (de) Verfahren zur herstellung von vitaminpulvern
EP0200068A3 (de) Arzneizubereitung enthaltend Dihydropyridine und Verfahren zu ihrer Herstellung
ATE17727T1 (de) Alkylenverbrueckte guanidinothiazolderivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel.
DE3481510D1 (de) Optisch aktive verbindungen mit antitassiver und zentral-sedativer wirkung, ein verfahren zu deren herstellung und diese enthaltende zusammensetzungen.
IL58064A0 (en) Fluorinated polyene compounds their preparation and pharmaceutical compositions containing them
EP0382779A4 (en) Tocopherol-based pharmaceutical systems
ATE287879T1 (de) Verfahren zur herstellung von isoflavonen
AU4884596A (en) Process for the preparation of a solid pharmaceutical dosage form
DE59408450D1 (de) Wässriges Liposomensystem sowie Verfahren zur Herstellung eines derartigen Liposomensystems
ATE112277T1 (de) Neues s-timolol derivat und verfahren zu seiner herstellung.
CN106619544A (zh) 一种苯磺顺阿曲库铵冻干粉针制剂

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee